We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+17.99%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.06B
AUM Growth
-$12.1M
Cap. Flow
-$142M
Cap. Flow %
-13.41%
Top 10 Hldgs %
37.54%
Holding
501
New
15
Increased
262
Reduced
172
Closed
24

Top Buys

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$6.54M
2
IAUM icon
iShares Gold Trust Micro
IAUM
+$4.59M
3
GLDM icon
SPDR Gold MiniShares Trust
GLDM
+$3.58M
4
INTU icon
Intuit
INTU
+$3.2M
5
TMUS icon
T-Mobile US
TMUS
+$2.41M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$17.2M
2
MSFT icon
Microsoft
MSFT
+$10M
3
NVDA icon
NVIDIA
NVDA
+$9.7M
4
AMZN icon
Amazon
AMZN
+$7.99M
5
AVGO icon
Broadcom
AVGO
+$6.64M

Sector Composition

Rank Sector Weight
1 Technology 38.15%
2 Healthcare 22.68%
3 Communication Services 12.64%
4 Consumer Discretionary 11.62%
5 Consumer Staples 3.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TJX icon
226
TJX Companies
TJX
$169B
$614K 0.06%
4,970
– –
TAL icon
227
TAL Education Group
TAL
$6.58B
$607K 0.06%
59,400
-80,600
-58% -$833K
WVE icon
228
Wave Life Sciences
WVE
$1.03B
$607K 0.06%
93,370
+40,850
+78% +$270K
LEGN icon
229
Legend Biotech
LEGN
$3.99B
$582K 0.05%
16,406
+21
+0.1% +$680
PRCT icon
230
Procept Biorobotics
PRCT
$1.22B
$576K 0.05%
+10,000
New +$565K
OCUL icon
231
Ocular Therapeutix
OCUL
$2.25B
$575K 0.05%
61,995
+30,460
+97% +$238K
IQV icon
232
IQVIA
IQV
$39.8B
$552K 0.05%
3,500
– –
IMVT icon
233
Immunovant
IMVT
$8.8B
$549K 0.05%
34,329
+258
+0.8% +$3.9K
CRNX icon
234
Crinetics Pharmaceuticals
CRNX
$8.96B
$541K 0.05%
18,815
+151
+0.8% +$4.66K
XPEV icon
235
XPeng
XPEV
$11.2B
$536K 0.05%
30,000
-2,000
-6% -$39K
CDW icon
236
CDW
CDW
$17.1B
$534K 0.05%
2,990
-282
-9% -$47.9K
QQQ icon
237
Invesco QQQ Trust
QQQ
$481B
$525K 0.05%
950
+360
+61% +$179K
RACE icon
238
Ferrari
RACE
$71.6B
$510K 0.05%
1,039
-200
-16% -$92.9K
AMRX icon
239
Amneal Pharmaceuticals
AMRX
$6.15B
$509K 0.05%
62,949
+775
+1% +$5.84K
MIRM icon
240
Mirum Pharmaceuticals
MIRM
$6.04B
$506K 0.05%
9,949
+118
+1% +$5.25K
ARM icon
241
Arm
ARM
$290B
$491K 0.05%
3,037
-197
-6% -$24.5K
ALVO icon
242
Alvotech
ALVO
$1.36B
$489K 0.05%
53,590
-6,882
-11% -$64.6K
XENE icon
243
Xenon Pharmaceuticals
XENE
$6.31B
$482K 0.05%
15,412
+59
+0.4% +$1.93K
GFS icon
244
GlobalFoundries
GFS
$29.2B
$480K 0.05%
12,554
-1,096
-8% -$39.7K
IBRX icon
245
ImmunityBio
IBRX
$8.2B
$468K 0.04%
177,271
+30,813
+21% +$82.9K
TWST icon
246
Twist Bioscience
TWST
$7.85B
$443K 0.04%
12,034
+69
+0.6% +$2.38K
LGND icon
247
Ligand Pharmaceuticals
LGND
$5.85B
$441K 0.04%
3,875
+13
+0.3% +$1.39K
HSAI
248
Hesai Group
HSAI
$2.99B
$439K 0.04%
20,000
-43,000
-68% -$757K
ARWR icon
249
Arrowhead Research
ARWR
$12.3B
$438K 0.04%
27,737
+2,444
+10% +$35.1K
APLS
250
DELISTED
Apellis Pharmaceuticals
APLS
$437K 0.04%
25,243
+67
+0.3% +$1.24K
8 9
10
11 12

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q2 2025 Portfolio in Review

As of Q2 2025, China Universal Asset Management Company held 501 positions worth $1.06B, down 1.1% from $1.07B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

China Universal Asset Management Company withdrew a net $142M in Q2 2025, closing 24 positions and reducing 172 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $2.81M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 37% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, China Universal Asset Management Company opened a new position in Tencent Music worth $1.66M.

  • China Universal Asset Management Company's largest Q2 2025 buy was Tencent Music: 85,000 shares worth $1.66M.
  • China Universal Asset Management Company added most to SPDR Gold Trust in Q2 2025, an estimated $6.54M increase.
  • China Universal Asset Management Company's biggest Q2 2025 reduction was Apple, cutting an estimated $17.2M.
  • China Universal Asset Management Company fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $2.81M.
  • China Universal Asset Management Company's ten largest holdings make up 38% of its $1.06B portfolio in Q2 2025.
  • China Universal Asset Management Company opened 15 new positions and closed 24 in Q2 2025.
  • China Universal Asset Management Company's portfolio value fell 1.1% quarter-over-quarter to $1.06B.

Based on China Universal Asset Management Company's 13F filing for Q2 2025, filed 28 Aug 2025.